Vaccine Polyvalent

A multivalent vaccine is a vaccine that contains several antigens that trigger an immune response to several different infections. It can be used to prevent multiple infections at the same time, reducing the risk of contracting multiple infections and reducing the number of vaccines needed.

A polyvalent vaccine may contain antigens from different types of viruses, bacteria or parasites that can cause various diseases. For example, a multivalent influenza vaccine may contain antigens from several strains of influenza, and a pneumococcal vaccine may contain antigens from different types of pneumococci.

The use of a polyvalent vaccine has a number of advantages. First, it may provide better protection against multiple infections than using individual vaccines against each infection. Second, it could reduce the number of vaccines needed, which could reduce the cost of vaccination and reduce the burden on the health care system.

However, the use of a polyvalent vaccine also has its disadvantages. First, some antigens may be less effective than the antigens contained in individual vaccines. Secondly, vaccination with a polyvalent vaccine may cause side effects such as allergic reactions or fever.

Overall, the polyvalent vaccine is an effective tool for preventing multiple infections and may be useful for people who are at high risk of contracting multiple infections. However, before using the polyvalent vaccine, it is necessary to take into account its possible disadvantages and consult a doctor for advice.

The vaccine is polyvalent.

A polyvalent vaccine is a medical product that is a multicomponent immunizing composition or an adjuvant to a vaccine with an adjuvant. Such a vaccine may contain several vaccines against different infections. The use of a polyvalent vaccine is used in the prevention of diseases. It is known that epidemiological studies have proven the danger of using cross-serological reactions of certain serotypes of intestinal antigens in certain groups of the population - children in the first months of life, women with immunodeficiencies, etc. It is to prevent such a complication that a polyvalent vaccine is used.

Contraindications to the administration of a vaccine preparation are divided into absolute (for example, a severe allergic reaction, anaphylactic shock to the pertussis vaccine protein) and relative (for example, the presence of an inflammatory process in the acute stage). For people with allergic reactions to aminoglycoside agents, sensitivity to them is determined using an allergy diagnostic system; for this, 0.1 ml of the allergen is injected into the subcutaneous tissue of the shoulder. After a preliminary injection of antihistamines, a subcutaneous injection of an allergen solution is administered for 12 hours. Blood for analysis is collected by venous route after 24 hours. Diagnosis is carried out no earlier than 5-7 days after the previous test.